Year: 2016
Type: dissertation
Abstract: Circadian rhythms, defined by a set of biological clocks, are crucial to virtually all biological processes. A central clock is located in the hypothalamus and synchronises peripheral clocks, located in all cells. Disruptions in this complex circadian clock system, reflected by clock gene expression alterations, is associated with several diseases. Obstructive sleep apnea (OSA) is one of the most common sleep disorders. Untreated OSA has been implicated as risk factors for the development of several diseases, among which metabolic and cardiovascular disorders. However, OSA is still highly underdiagnosed, which limits its treatment. Consequently, it is urgent to find OSA biomarkers, molecular reflexes of its severity, and clock genes constitute promising candidates. Indeed, Several OSA molecular outcomes may contribute to clock genes expression alterations. In this context, the present work has three main aims: 1) to investigate the impact of OSA on peripheral clock genes, before and after treatment; 2) to find potential OSA biomarkers; 3) to evaluate the impact of neuropeptide Y (NPY) on hypothalamic clock genes. We investigated the circadian rhythm integrity of an OSA cohort, by assessing a circadian rhythm marker (body temperature) and clock genes expression (Per1-3; Cry1-2; BMAL1; CLOCK; CK1ε; DEC1-2), at four time points (8 a.m.; 11 a.m.; 4.30 p.m. and 10.30 p.m.), in peripheral blood mononucleate cells (PBMCs), before and after OSA treatment by continuous positive airway pressure (CPAP). In parallel, using a mouse hypothalamic cell line (mHypoN42), we assessed the impact of NPY on clock genes levels, at different circadian times (CTs). The results showed that OSA patients have disruptions in the typical oscillatory expression of several clock genes and abnormal clock genes messenger RNA levels. In addition, the expression of specific clock genes, at specific times, showed to correlate with OSA severity. We observed that the mRNA levels of the clock gene Cry1, at 8 a.m., have a negative correlation with OSA severity, which suggests that Cry1 has potential as a putative OSA biomarker. In hypothalamic cells, NPY changed clock genes expression, in a CT dependent manner. However, a short term constitutive expression of NPY is not sufficient to change clock genes modulation in hypothalamic cells. Thus, the expression of specific clock genes, at specific times of the day, could be used as OSA biomarkers and reflect OSA severity. Further investigations may allow a more specific and early OSA diagnosis and, consequently, a more personalized and effective treatment.
Author: Gaspar, Laetitia da Silva
Institution: University of Coimbra
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Keywords: circadian rhythm, clock genes, obstructive sleep apnea, biomarkers, neuropeptide Y, hypothalamus, CRY1, body temperature, CPAP therapy, circadian gene expression, OSA severity, peripheral blood mononuclear cells, metabolic disorders, cardiovascular disease, circadian clock disruption, CK1ε, Bmal1
Open Access status: green
Award: CNC. IBILI
OpenAlex ID: W7224055168
